Literature DB >> 6374180

Migration and granulomatous reaction after periurethral injection of polytef (Teflon).

A A Malizia, H M Reiman, R P Myers, J R Sande, S S Barham, R C Benson, M K Dewanjee, W J Utz.   

Abstract

Although patients with urinary incontinence have been treated successfully by periurethral injection of polytef paste, this study in continent animals demonstrates migration of polytef particles from the injection site. We injected polytef paste periurethrally into female dogs and male monkeys. Particles were found at 50 to 70 days in pelvic nodes in six of seven animals and lungs in four of seven (the kidneys and brain were not studied); and at 10 1/2 months in pelvic nodes, lungs, and brain in seven of seven; kidneys in four of seven; and spleen in two of seven. X-ray microanalysis confirmed that the particles were polytef. At 10 1/2 months, polytef granulomas were found at all injection sites and some sites of distant migration. Since these granulomas signify chronic foreign-body reaction, we believe that until the long-term effects in humans are known, polytef paste should not be used in children or young adults with normal life expectancy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6374180

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  66 in total

Review 1.  [Tissue engineering in urology. Basic principles and application].

Authors:  G Bartsch; A Atala
Journal:  Urologe A       Date:  2003-02-28       Impact factor: 0.639

2.  Novel injectable urethral bulking agents for the treatment of urinary incontinence.

Authors:  O Jordan; E Doelker; N Defabiani; A Caviezel; C Iselin
Journal:  J Mater Sci Mater Med       Date:  2004-04       Impact factor: 3.896

Review 3.  [Therapeutic options for primary vesicoureteral reflux: endoscopic vs open surgical approach].

Authors:  C Ziesel; S Frees; J W Thüroff; R Stein
Journal:  Urologe A       Date:  2012-03       Impact factor: 0.639

4.  Female incontinence in childhood: aetiopathogenetic assessment and therapeutic approach.

Authors:  P Caione; M De Gennaro; A Zaccara; N Capozza
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

Review 5.  [Therapy related alterations to the thyroid gland].

Authors:  S Y Sheu; S Levin; K W Schmid
Journal:  Pathologe       Date:  2006-02       Impact factor: 1.011

6.  [Vesicorenal reflux in childhood].

Authors:  G Zöller; C Radmayr; C Schwentner; C Persson de Geeter; R Stein; R H Ringert
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

7.  Management of vesicoureteral reflux.

Authors:  Ellen Shapiro; Brent Snow; Mark Zaontz
Journal:  Rev Urol       Date:  2003

8.  Tegresstrade mark Urethral Implant Phase III Clinical Experience and Product Uniqueness.

Authors:  Roger R Dmochowski
Journal:  Rev Urol       Date:  2005

9.  Current use of injectable agents for female stress urinary incontinence.

Authors:  Sender Herschorn
Journal:  Rev Urol       Date:  2005

10.  Combination of calcium hydroxyapatite and autologous blood for endoscopic treatment of vesicoureteral reflux in children.

Authors:  Roozbeh Tanhaeivash; Abdol-Mohammad Kajbafzadeh; Atefeh Zeinoddini; Neda Khalili; Mona Vahidi Rad; Reza Heidari
Journal:  Int Urol Nephrol       Date:  2014-02-20       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.